Faculty

Ruanne Barnabas

Adjunct Professor, Epidemiology
Professor, Global Health

206-520-3813
rbarnaba@uw.edu

Education

DPhil Epidemiology, University of Oxford, 2005
MSc Epidemiology, University of Oxford, 2000
MBChB Medicine & Surgery, University of Cape Town (South Africa), 1997

Contact

206-520-3813
rbarnaba@uw.edu

Box 359927
325 Ninth Ave
Seattle, WA 98104

Bio

Ruanne Barnabas is an Associate Professor in Global Health and Medicine at the University of Washington and affiliate at the Fred Hutchinson Cancer Research Center. She is a South African Physician-Epidemiologist. Her research focuses on interventions for HIV and STD treatment and prevention, and, more recently on COVID-19 prevention. She is the protocol chair of the Delivery Optimization for antiretroviral (DO ART) Study, which will evaluate the effectiveness and cost-effectiveness of decentralized, community-based ART initiation compared to clinic- based care. Also, she is the Principle Investigator for the COVID-19 PEP Study. She is the protocol chair for the Kenya Single-dose HPV vaccine Efficacy (KEN SHE) Study, which will evaluate the efficacy of single-dose HPV vaccination for women. She leads the cost-effectiveness evaluation of other projects including scale-up of cervical cancer and HIV treatment and prevention in high burden settings. Her projects use clinical trial data and health economic modeling to estimate the potential impact of interventions. The ultimate aim of her work is to identify effective and efficient treatment and prevention public health strategies.

Recent Publications (PubMed)

Evaluation of Women's Empowerment in a Community-Based Human Papillomavirus Self-Sampling Social Entrepreneurship Program (Hope Project) in Peru: A Mixed-Method Study.
(2022)
Front Public Health 10(): 858552
Shin MB, Garcia PJ, Dotson ME, Valderrama M, Chiappe M, Ramanujam N, Krieger M, Ásbjörnsdóttir K, Barnabas RV, Iribarren SJ, Gimbel S

Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial.
(2022 Jun 16)
Trials 23(1): 495
Stewart J, Bukusi E, Sesay FA, Oware K, Donnell D, Soge OO, Celum C, Odoyo J, Kwena ZA, Scoville CW, Violette LR, Morrison S, Simoni J, McClelland RS, Barnabas R, Gandhi M, Baeten JM

Efficacy of single-dose HPV vaccination among young African women.
(2022 Jun)
NEJM Evid 1(5): EVIDoa2100056
Barnabas RV, Brown ER, Onono MA, Bukusi EA, Njoroge B, Winer RL, Galloway DA, Pinder LF, Donnell D, Wakhungu I, Congo O, Biwott C, Kimanthi S, Oluoch L, Heller KB, Leingang H, Morrison S, Rechkina E, Cherne S, Schaafsma TT, McClelland RS, Celum C, Baeten JM, Mugo N

Isoniazid preventive therapy and TB transcriptional signatures in people with HIV.
(2022 May 24)
AIDS
Valinetz ED, Matemo D, Gersh JK, Joudeh LL, Mendelsohn SC, Scriba TJ, Hatherill M, Kinuthia J, Wald A, Cangelosi GA, Barnabas RV, Hawn TR, Horne DJ

Implementation of a fully remote randomized clinical trial with cardiac monitoring.
(2021)
Commun Med (Lond) 1(): 62
Mayfield JJ, Chatterjee NA, Noseworthy PA, Poole JE, Ackerman MJ, Stewart J, Kissinger PJ, Dwyer J, Hosek S, Oyedele T, Paasche-Orlow MK, Paolino K, Friedman PA, Waters C, Moreno J, Leingang H, Heller KB, Morrison SA, Krows ML, Barnabas RV, Baeten J, Johnston C, COVID-19 Early Treatment Team., Sridhar AR

Show complete publication list